Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2001
01/10/2001EP1066271A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins
01/10/2001EP1066261A1 Pyridine derivative and pharmaceutical containing the same
01/10/2001EP1066260A1 Pyridine/picoline production process
01/10/2001EP1066255A1 Method for producing lactams using oligophosphate catalysts
01/10/2001EP1066251A1 Method for the production of 1,3-disubstituted 2-nitroguanidines
01/10/2001EP1066247A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
01/10/2001EP1066246A1 Novel cationic couplers and their use for oxidation dyeing
01/10/2001EP1066034A1 Oxy-vanadium (iv) complexes having spermicidal activity
01/10/2001EP1066022A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
01/10/2001EP1056722A4 Bisulfate salt of hiv protease inhibitor
01/10/2001EP0854899B1 Fluorine-substituted alkenyl liquid crystalline compounds
01/10/2001CN1279682A bicyclic kinase inhibitors
01/10/2001CN1279672A Pyridazine derivatives and drugs containing the same as the active ingredient
01/09/2001US6172261 Biosynthesis using chain extension
01/09/2001US6172228 Process for producing piperazinesulfonamide derivatives and salts thereof
01/09/2001US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same
01/09/2001US6172108 Hydrazide compounds
01/09/2001US6172103 Treating bone disorders, osteoporosis, and arthritis
01/09/2001US6172091 Metabolic calcium imbalance and osteoporosis
01/09/2001US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/09/2001US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
01/09/2001US6172064 Formamides as therapeutic agents
01/09/2001US6172060 Therapy for sexual disorders
01/09/2001US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents
01/09/2001US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
01/09/2001CA2203384C Conjugated n-fluoropyridinium salt-containing polymer and use of the same
01/09/2001CA2111854C Orally active antiviral compounds
01/09/2001CA2031766C 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
01/04/2001WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives
01/04/2001WO2001000595A1 Method for producing 2-heterocyclyl methyl benzoic acid derivatives
01/04/2001WO2001000581A1 Ligands based on chiral 2-amino-2'-hydroxy-1,1'-binaphthyl and related frameworks for asymmetric catalysis
01/04/2001WO2001000580A1 2-(optionally substituted benzoylamino)-6-(optionally substituted phenoxy)pyridine derivatives, process for the preparation thereof and herbicides
01/04/2001WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
01/04/2001WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/04/2001WO2001000575A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
01/04/2001WO2001000548A1 Compound having tetrahydronaphthalene skeleton and liquid crystal composition containing the same
01/04/2001WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
01/04/2001WO2001000208A1 Substituted pyridones having cytokine inhibitory activity
01/04/2001WO2001000206A1 Vla-4 inhibitor compounds
01/04/2001WO2001000197A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001WO2001000021A1 Pyrithione biocides enhanced by silver, copper, or zinc ions
01/04/2001WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia
01/04/2001WO2000030589A3 Synthesis of intermediates useful in preparing tricyclic compounds
01/04/2001WO1998005610A3 Process for preparing fluorine-containing compounds
01/04/2001DE19930075A1 Neue Amino- und Amidosulfonamide als antivirale Mittel New amino and Amidosulfonamide as antiviral agents
01/04/2001CA2376892A1 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/04/2001CA2369308A1 Vla-4 inhibitor compounds
01/04/2001CA2369145A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
01/03/2001EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists
01/03/2001EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments
01/03/2001EP1064265A1 Synthesis of 3-amino-2-chloro-4-methylpyridine from malononitrile and acetone
01/03/2001EP1064264A1 Cytotoxic metal chelators and methods for making and using same
01/03/2001EP1064263A2 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
01/03/2001EP1063984A1 Inflammatory cell inhibitors
01/03/2001EP0832057B1 Diaromatic propynyl or dienyl compounds
01/03/2001CN1278807A Herbicidal N-alkenyl Heteroaryloxyacetamides
01/03/2001CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors
01/03/2001CN1278793A Sulfonyl derivatives
01/03/2001CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides
01/03/2001CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
01/03/2001CN1278785A Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
01/03/2001CN1060161C N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediats of derlvatives and process for production thereof
01/02/2001US6169184 Process for the production of substituted phenylpyridines
01/02/2001US6169183 Process for preparing pyridinecarboxylic esters
01/02/2001US6169101 Fungicides
01/02/2001US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells
01/02/2001US6168838 Fluorinated phenantrene derivatives for liquid crystal mixtures
01/02/2001CA1341163C Oxime ether derivatives, their preparation and fungicides containing these derivatives
01/02/2001CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues
12/2000
12/28/2000WO2000078756A1 Thiophene-ethyl thiourea compounds and their use in the treatment of hiv
12/28/2000WO2000078755A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000WO2000078721A1 Phenetyl-thiourea compounds for treating hiv infections
12/28/2000WO2000078712A1 Substituted arylmalonic acid dinitriles as intermediates for the prepartion of herbicides
12/28/2000WO2000078708A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000WO2000078315A1 Cyclohexenyl-ethyl-thiourea compounds and use
12/28/2000WO2000078303A1 Non-malignant disease treatment with ras antagonists
12/28/2000DE19929348A1 Pure 2-heterocyclylmethyl-benzoic acid derivative preparation in high yield, for use as pharmaceutical or agrochemical intermediate, from phthalide compound and nitrogen-containing heterocycle
12/28/2000CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000CA2375342A1 Phenetyl-thiourea compounds for treating hiv infections
12/28/2000CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000CA2368827A1 New intermediates
12/27/2000EP1062255A1 Homopolymer of ethylene
12/27/2000EP1062251A1 Polymerisation catalyst
12/27/2000EP1062250A1 Polymerisation catalysts
12/27/2000EP1062249A1 Polymerisation catalysts
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061921A1 Vitronectin receptor antagonists
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1012141A4 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0808304B1 2,3-substituted pyridines for the treatment of inflammation
12/27/2000CN1278272A Polymerization catalysts
12/27/2000CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor
12/27/2000CN1278250A Vitronectin receptor antagonists
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278245A Malonic acid based matric metalloproteinase inhibitors
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1278167A Amide derivatives